Airway Medix Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	1.28	1.75	-11.74	-3.28	-7.04	-2.37
Depreciation & Amortization	0.26	0.08	0.08	-	0.03	0.15
Asset Writedown & Restructuring Costs	-9.99	-9.99	-	-	14.25	0.02
Loss (Gain) From Sale of Investments	-	-	-	0.13	-27.31	-
Stock-Based Compensation	0.03	0.03	0.62	5.23	-	-
Other Operating Activities	2.67	1.5	5.37	3.05	-1.39	-0.06
Change in Accounts Receivable	0.78	0.14	-0.22	-4.01	-	-
Change in Inventory	0.05	-0.07	-	-	-	-
Change in Accounts Payable	3.94	3.18	-1.71	-5.32	-	-
Change in Other Net Operating Assets	-	-	-	0	-	-
Operating Cash Flow	-0.98	-3.38	-7.59	-4.2	-21.46	-2.26
Capital Expenditures	-0.3	-0.24	-0.02	-	-	-
Investing Cash Flow	-0.3	-0.24	-0.07	-	-	-
Long-Term Debt Issued	-	2.53	9.56	4.33	3.71	9.86
Total Debt Issued	2.51	2.53	9.56	4.33	3.71	9.86
Long-Term Debt Repaid	-	-0.91	-0.43	-2.39	-	-1.13
Total Debt Repaid	-0.99	-0.91	-0.43	-2.39	-	-1.13
Net Debt Issued (Repaid)	1.52	1.62	9.14	1.94	3.71	8.73
Issuance of Common Stock	-	-	-	2.91	-	-
Financing Cash Flow	1.52	1.62	9.14	4.85	3.71	8.73
Foreign Exchange Rate Adjustments	0.01	0.01	-0.01	0	-0.05	0.05
Miscellaneous Cash Flow Adjustments	-0	-	-	-	15.6	-5
Net Cash Flow	0.25	-1.99	1.46	0.65	-2.19	1.51
Free Cash Flow	-1.28	-3.62	-7.61	-4.2	-21.46	-2.26
Free Cash Flow Margin	-1437.08%	-90475.00%	-63408.33%	-34958.33%	-357600.00%	-880.55%
Free Cash Flow Per Share	-0.01	-0.04	-0.10	-0.06	-0.37	-0.04
Levered Free Cash Flow	-2.75	-4.43	-3.78	-	6.77	-15.58
Unlevered Free Cash Flow	-1.52	-3.4	-3.33	-	7.17	-15.16
Change in Working Capital	4.76	3.25	-1.93	-9.33	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.